The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of mirvetuximab soravtansine (IMGN853) and gemcitabine (G) in patients with FOLR1-positive recurrent epithelial ovarian (EOC), endometrial cancer (EC), or triple-negative breast cancer (TNBC).
 
Mihaela C. Cristea
Honoraria - AstraZeneca; Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca
Research Funding - Trovagene
 
Paul Henry Frankel
Honoraria - Geron; Transenterix
Other Relationship - FlexSim; FlexSim
 
Timothy W. Synold
No Relationships to Disclose
 
Joanne E. Mortimer
Honoraria - Novartis
Consulting or Advisory Role - Novartis; Pfizer; Puma Biotechnology
 
Daphne B. Stewart
No Relationships to Disclose
 
Edward Wenge Wang
No Relationships to Disclose
 
Alex Jung
No Relationships to Disclose
 
Sharon P. Wilczynski
No Relationships to Disclose
 
Gottfried E. Konecny
Speakers' Bureau - AstraZeneca; Clovis Oncology; Tesaro
Research Funding - Merck
Travel, Accommodations, Expenses - Novartis
 
Dia Parungao
No Relationships to Disclose
 
Melissa Eng
No Relationships to Disclose
 
Lindsay Kilpatrick
No Relationships to Disclose
 
Yi-Jen Chen
No Relationships to Disclose
 
Scott Glaser
Employment - City of Hope
Honoraria - Reflexion Medical
 
Ernest Soyoung Han
No Relationships to Disclose
 
Thanh Hue Dellinger
No Relationships to Disclose
 
Amy Hakim
No Relationships to Disclose
 
Stephen Lee
No Relationships to Disclose
 
Robert Morgan
No Relationships to Disclose
 
Mark Tsuneo Wakabayashi
No Relationships to Disclose